Clinical Pharmacology of Gastrointestinal and Liver Disease An Issue of Gastroenterology Clinics
Richard H. Hunt, MB, FRCP, FRCPEd, FRCPC, FACG, AGAF
Dr. Hunt has assembled a group of top experts to discuss the newest and most successful medical therapies to treat gastrointestinal diseases. The issue is divided into sections devoted to each of these diseases states or disorders: acid-related disorders, functional gastrointestinal disorders, inflammatory bowel disease, gastrointestinal oncology, and hepatitis; the last 2 articles address the future directions in gastrointestinal pharmacotherapy. Articles of special interest include those on Anti-TNFa Drugs and New Biological Drugs for IBD, 5-ASA Drugs and Modified Formulations, and Potential for Manipulation of the Microbiome in Gastrointestional Disease.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.